Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Reports
Biologics Pricing Report
Oral Solid Dose Market Report
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Supply Chain
128 Articles Available
1
6
Can't find what you're looking for? Try our
advanced search
.
Digital Transformation
Seamlessly Sharing Supply Chain Information to Deliver Measurable Efficiencies for Clients
PAP-Q4-20-CL-020
Small Molecule
The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic
PAP-Q4-20-CL-025
COVID-19 Vaccine Distribution
Preparing for COVID-19 Vaccine Distribution Despite Tight Shipping Capacity
PAP-Q4-20-CL-006
Supply Chain
Nationalism and the Pharmaceutical Supply Chain
PAP-Q4-20-CL-012
The Future of Healthcare
How Does Yourway Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-016
The Future of Healthcare
How Does Arranta Bio Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-007
The Future of Healthcare
How Does SPI Pharma Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-009
The Future of Healthcare
How Does TriRx Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-004
COVID-19 Impacts
Q: What do you think is the greatest lesson learned from the COVID-19 pandemic, and what lasting impacts do you foresee over the next 5–10 years?
PAP-Q4-20-NI-006
Leadership
A CEO’s Perspective: Positioning a CDMO for Significant Growth
PAP-Q3-20-CL-008
Supply Chain
Introduction: The Evolving Pharmaceutical Supply
PAP-Q3-20-NI-12
Feature Story
The COVID-19 Pandemic Magnifies Pharmaceutical Supply Chain Issues
PAP-Q3-20-NI-002
Feature Story
The Growing Importance of Local Manufacturing and Nearby Outsourcing Partners
PAP-Q3-20-NI-003
Feature Story
Rethinking the Global Pharmaceutical Supply Chain Post-COVID-19
PAP-Q3-20-NI-004
The Future of Healthcare
How Is SPI Pharma Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-004
The Future of Healthcare
How Is TriRx Pharmaceutical Services Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-006
The Future of Healthcare
How Is Arranta Bio Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-009
The Future of Healthcare
How Is Yourway Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-012
Supply Chain Risk
The Precarious Pharmaceutical Supply Chain: To Reshore or Not to Reshore – Part 1
PAP-Q3-20-CL-020
Post COVID-19 Supply Chain
Q: How are you rethinking your supply chain and operational fitness in light of the COVID-19 pandemic?
PAP-Q3-20-NI-007
Roundtable
Q: What steps is your company taking to address drug pricing issues?
PAP-Q3-20-NI-008
CDMO
Positioning a CDMO to Meet Future Needs
PAP-Q2-20-CL-006
Digitization
The Power of Digital Transformation
PAP-Q2-20-CL-029
Cell Therapies
A Personalized Cell Therapy Chain Management Platform
PAP-Q2-20-CL-032
1
6
»
